Skip to main content
main-content

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Editors' pick

07-12-2019 | Continuous glucose monitoring | Highlight | News

CGM measures have variable correlation with HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

The continuing evolution of GLP-1RAs – webcast available now!

Don’t miss out on this expert-led webcast on the continuing evolution of glucagon-like peptide-1 receptor agonists, chaired by Professor John Wilding.

07-03-2019 | Semaglutide | At a glance | Article

A quick guide to the PIONEER trials

medwireNews rounds up the ongoing, reported, and published trials from the PIONEER oral semaglutide program.

Latest from across the site

07-17-2019 | Diabetes self-management | News

Factors influencing intended intensity of diabetes care highlighted

Decisions about future intensity of care made during a person-centered type 2 diabetes consultation depend on both disease- and patient-related factors, report researchers from the Netherlands.

07-16-2019 | Insulin | News

Early hypoglycemia common after starting basal insulin therapy

Almost one in 10 people with type 2 diabetes who begin basal insulin therapy through the Medicare health program experience hypoglycemia within 6 months, US research suggests.

07-15-2019 | Medications | News

Second-line type 2 diabetes therapies vary globally

Second-line therapy choices for people with type 2 diabetes vary widely throughout the world and are influenced not only by clinical characteristics but also non-medical factors such as affordability and availability, results from the DISCOVER study show.

07-12-2019 | Continuous glucose monitoring | Highlight | News

CGM measures have variable correlation with HbA1c

Glycated hemoglobin levels correlate strongly with continuous glucose monitoring-measured average blood glucose and hyperglycemia, but poorly with hypoglycemia, say researchers.

07-11-2019 | Insulin glargine | News

Support for Gla-300 use in older people with type 2 diabetes

Older type 2 diabetes patients receiving basal insulin treatment who switch to glargine 300 units/mL experience greater or similar improvements in glycemic control compared with those switching to a first-generation basal insulin, with lower hypoglycemia risk, researchers report.

07-10-2019 | Diet | News

Better evidence needed for roles of specific dietary factors in type 2 diabetes

The quality of the evidence for the role of specific dietary factors in type 2 diabetes incidence is generally poor and requires better conducted research with more detailed assessments, suggests an umbrella review of meta-analyses.

ADVERTISEMENT

Flash glucose monitoring technology

Downloadable slide sets from key clinical trials in people with diabetes

Meet our Editorial Board

New Content Item Meet our Advisory Board

Latest from us on Twitter

Trending this week

Image Credits